Posted inTC Aarogya Setu rolls out new feature to update Vaccination Status by CS SURBHI SAXENA June 1, 2021
Posted inTC Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha by CS SURBHI SAXENA May 15, 2021
Posted inTC DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years by CS SURBHI SAXENA May 13, 2021
Posted inTC Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals by CS SURBHI SAXENA April 25, 2021
Posted inTC PM Modi interacted with Chief Ministers of all states by CS SURBHI SAXENA January 12, 2021January 12, 2021
Posted inTC DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency by CS SURBHI SAXENA January 4, 2021January 4, 2021
Posted inTC India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials by CS SURBHI SAXENA December 18, 2020December 18, 2020
